Censorship and COVID

A discussion unfolds around the controversial topic of Ivermectin as a potential treatment for COVID, highlighting the challenges faced by researchers who have been silenced and demonetized for their views. Insights reveal the complexities of gain-of-function research and the implications of censorship in the scientific community. Hopes are expressed for potential changes in leadership that could foster a more open dialogue on these critical issues.